Subscribe to our Newsletters !!
Few developments in science and technology have be
Even well‑validated LC–UV methods can produ
The recent rabies death of an 11 year old Canadian
Alembic Pharmaceutica
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Mi
Researcher from Fred Hutchinson Cancer Research Center suggests a type of immunotherapy which includes engineering of T-Cells in laboratory along with protein tag that tracks immune cells to directly attack and killing cancer cells. The appropriate study recently appeared in Nature Biotechnology.
Dr. Stanley Riddell lead author and researcher and his team inform that this technique not yet tested in humans. The technique no doubt will boost the performance of modern used immunotherapy.Juno Therapeutics a Biotechnology company initially formed a technique with researcher of Fred Hutchinson Cancer Research Center and Seattle Children's Research Institute has licenses to this technology for oncology related treatment.
Note: The above story is for information purposes only for more information go through story source.
Story Source: Fred Hutchinson Cancer Research Center
Journal References
Lingfeng Liu, Daniel Sommermeyer, Alexandra Cabanov, Paula Kosasih, Tyler Hill, Stanley R Riddell. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nature Biotechnology, 2016; DOI: 10.1038/nbt.3461
